- Home
- GPCR vs MFA Comparison
GPCR vs MFA Comparison
Compare GPCR & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- MFA
- Stock Information
- Founded
- GPCR 2016
- MFA 1997
- Country
- GPCR United States
- MFA United States
- Employees
- GPCR N/A
- MFA N/A
- Industry
- GPCR
- MFA Real Estate Investment Trusts
- Sector
- GPCR
- MFA Real Estate
- Exchange
- GPCR Nasdaq
- MFA Nasdaq
- Market Cap
- GPCR 1.1B
- MFA 1.1B
- IPO Year
- GPCR 2023
- MFA N/A
- Fundamental
- Price
- GPCR $23.82
- MFA $9.57
- Analyst Decision
- GPCR Strong Buy
- MFA Buy
- Analyst Count
- GPCR 9
- MFA 5
- Target Price
- GPCR $77.50
- MFA $13.00
- AVG Volume (30 Days)
- GPCR 1.1M
- MFA 1.3M
- Earning Date
- GPCR 05-08-2025
- MFA 05-06-2025
- Dividend Yield
- GPCR N/A
- MFA 15.05%
- EPS Growth
- GPCR N/A
- MFA N/A
- EPS
- GPCR N/A
- MFA 0.99
- Revenue
- GPCR N/A
- MFA $292,245,000.00
- Revenue This Year
- GPCR N/A
- MFA N/A
- Revenue Next Year
- GPCR N/A
- MFA $7.48
- P/E Ratio
- GPCR N/A
- MFA $9.66
- Revenue Growth
- GPCR N/A
- MFA 52.95
- 52 Week Low
- GPCR $13.22
- MFA $7.85
- 52 Week High
- GPCR $62.74
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- GPCR 51.16
- MFA 49.60
- Support Level
- GPCR $25.06
- MFA $9.40
- Resistance Level
- GPCR $27.50
- MFA $9.74
- Average True Range (ATR)
- GPCR 1.86
- MFA 0.23
- MACD
- GPCR -0.31
- MFA 0.04
- Stochastic Oscillator
- GPCR 28.77
- MFA 36.99
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.